Statement of Income (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
REVENUES:
Sales Revenue, Services, Net	$ 765,428	$ 693,895	$ 621,752
Sales Revenue, Goods, Net	308,080	287,185	285,896
Total Revenue	1,073,508	981,080	907,648
OPERATING EXPENSES:
Cost of services, exclusive of depreciation shown below	444,963	413,086	395,303
Cost of product sales, exclusive of depreciation shown below	218,005	208,733	198,066
General and administrative expenses, exclusive of depreciation shown below	51,988	43,185	41,141
Depreciation	24,168	21,762	22,126
Amortization	1,303	1,155	1,177
Other (income) expense, net	(338)	(4,121)	(919)
Income Before Interest Expense and Taxes	333,419	297,280	250,754
Loss on exchange of Senior Exchangeable Notes	0	0	1,012
Interest expense	9,317	8,820	10,900
Income before income tax expense	324,102	288,460	238,842
Income Tax Expense (Benefit)	80,908	71,848	54,198
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	243,194	216,612	184,644
Net Income (Loss) Attributable to Noncontrolling Interest	383	541	(40)
Net income attributable to Core Laboratories N.V.	$ 242,811	$ 216,071	$ 184,684
EARNINGS PER SHARE INFORMATION:
Earnings Per Share, Basic	$ 5.31	$ 4.58	$ 3.99
Earnings Per Share, Diluted	$ 5.28	$ 4.54	$ 3.82
Cash dividends per share	$ 1.28	$ 1.12
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:
Weighted Average Number of Shares Outstanding, Basic	45,692	47,211	46,286
Weighted Average Number of Shares Outstanding, Diluted	45,994	47,553	48,393